Ying-Ching E. Yang

Section 3 Electromagnetics

Joel T. Johnson, M. A. Tassoudji, J. Kong, 2009 .

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

Robert J. Mackenzie, Patrick M Liu, M. Haynes, 2022, The Lancet Respiratory Medicine.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Topical ocular drug delivery systems: Innovations for an unmet need.

Ying-Ching E. Yang, A. Lockwood, 2022, Experimental eye research.

Personality characteristics, defense styles, borderline symptoms, and non-suicidal self-injury in first-episode major depressive disorder

Z. Wu, Jiyang Pan, Ying-Ching E. Yang, 2023, Frontiers in Psychology.

0 Electromagnetic Wave Theory and Applications

Han, Lin, Gu, 2009 .

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.